- Home
- NQP vs CYRX Comparison
NQP vs CYRX Comparison
Compare NQP & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NQP
- CYRX
- Stock Information
- Founded
- NQP 1990
- CYRX 1999
- Country
- NQP United States
- CYRX United States
- Employees
- NQP N/A
- CYRX N/A
- Industry
- NQP Trusts Except Educational Religious and Charitable
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- NQP Finance
- CYRX Health Care
- Exchange
- NQP Nasdaq
- CYRX Nasdaq
- Market Cap
- NQP 413.9M
- CYRX 365.5M
- IPO Year
- NQP N/A
- CYRX N/A
- Fundamental
- Price
- NQP $10.78
- CYRX $7.85
- Analyst Decision
- NQP
- CYRX Strong Buy
- Analyst Count
- NQP 0
- CYRX 10
- Target Price
- NQP N/A
- CYRX $10.90
- AVG Volume (30 Days)
- NQP 58.4K
- CYRX 470.2K
- Earning Date
- NQP 01-01-0001
- CYRX 08-05-2025
- Dividend Yield
- NQP 3.21%
- CYRX N/A
- EPS Growth
- NQP N/A
- CYRX N/A
- EPS
- NQP N/A
- CYRX N/A
- Revenue
- NQP N/A
- CYRX $232,134,000.00
- Revenue This Year
- NQP N/A
- CYRX N/A
- Revenue Next Year
- NQP N/A
- CYRX $9.59
- P/E Ratio
- NQP N/A
- CYRX N/A
- Revenue Growth
- NQP N/A
- CYRX 11.75
- 52 Week Low
- NQP $9.65
- CYRX $4.58
- 52 Week High
- NQP $11.89
- CYRX $9.66
- Technical
- Relative Strength Index (RSI)
- NQP 33.64
- CYRX 59.21
- Support Level
- NQP $10.72
- CYRX $6.70
- Resistance Level
- NQP $11.16
- CYRX $8.45
- Average True Range (ATR)
- NQP 0.08
- CYRX 0.41
- MACD
- NQP -0.03
- CYRX 0.02
- Stochastic Oscillator
- NQP 13.64
- CYRX 65.71
About NQP Nuveen Pennsylvania Quality Municipal Income Fund
Nuveen Pennsylvania Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal and Pennsylvania income taxes and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal, Pennsylvania state and local income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.